We are monitoring the impact of COVID-19 on Biosimulation Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 8463
Share on
Share on

Global Biosimulation Market Analysis Report - By Product (Software, Molecular Simulation, In House, Contract Services), By Application (Clinical Trials, PKPD, ADME), By End User (Biotech, Pharma and Biotech Companies, CROs, Regulatory) & By Region - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 8463
Pages: 170

Tags: Tag2, Tag_3

Global Biosimulation Market Size & Growth - (2019-2024)

The global Dental Bone Graft Substitutes Market size is valued at USD1.60 billion in 2019 and is expected to reach a decent USD3.36 billion by 2024, growing at a CAGR of 16 %  during the forecast period 2019-2024.

Mounting cases of drug relapse due to acquired drug resistance in diseases such as tuberculosis and other bacterial infections are the biggest driver of the market.

Biosimulation facilitates continued efforts to gain better insights into the mechanism of drug resistance as well as to aid identification of therapies with high potency and lower susceptibility to drug resistance is driving the biosimulation market.

Presence of prolonged therapies, such as in the case of diabetes, results in poor patient adherence to and leads to the formation of drug-resistant bacteria, which ultimately hinders the biosimulation market.

 REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Application, Product, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Institut Straumann AG (Switzerland), Geistlich (Switzerland), DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), Dentium (Korea)

This research report on the Global Biosimulation Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Biosimulation Market - By Type                            

  • Synthetic bone graft          
  • Xenograft
  • Allograft  
  • Demineralized allograft

On the basis of type, Xenograft segment accounted for the largest share of the dental bone graft substitutes market. Advantages such as easy availability, sterility, reduced morbidity, long shelf life, and reduced risks of disease transfer offered by synthetic grafts are leading towards their increased usage as dental bone graft substitutes. Therefore, Synthetic Bone graft is anticipated to be the fastest-growing segment during the forecast period.

Biosimulation Market - By Application               

  • Socket Preservation           
  • Ridge Augmentation          
  • Periodontal Defect Regeneration
  • Implant Bone Regeneration          
  • Sinus lift  

On the basis of application, The Socket Prevention segment is expected to show the highest growth over the forecast period. Preservation of the socket is a technique used after tooth extraction to minimize bone loss from tooth socket in the alveolar bone. The factors driving growth in this segment of the dental bone graft substitutes market are increasing numbers of dental implant procedures and increasing awareness among people about oral care. Growing awareness over the latest products that promote better outcomes is surging the growth rate of dental bone graft substitutes market.

Biosimulation Market - By Product

  • Bio OSS    
  • Osteograf
  • Grafton   
  • Others

On the basis of product, Bio-Oss is one of the leading products on the substitute market for dental bone grafting. It is made from organic components of bovine bone, similar to human bone. It is in nature porous and non-antigenic. Increasing demand for the use of eco-friendly materials in order to follow environmental safety measures is lavishing the demand of the market. The Bio-Oss segment is anticipated to show the fastest growth during the forecast period. 

Regional Analysis

Due to the origin of implant dentistry in this region, and the high penetration of dental bone graft substitutes, Europe is anticipated to register the highest CAGR and dominate the market during the forecast period. Market growth is driven by the increased governmental spending on oral healthcare and the increasing aging population in the region.

The next in the lead in North America and Asia-Pacific is witnessed in holding dominant shares following North America. The increasing disposable income among the urban population, rising economic strength in major countries like India and China, and rapid industrialization & urbanization are the factors to provide growth opportunities for the Asia-Pacific dental bone graft substitutes market.

The top companies playing the prominent role in the Biosimulation Market profiled in the report are

  1. Institut Straumann AG (Switzerland)
  2. Geistlich (Switzerland)
  3. DENTSPLY International (U.S.)
  4. Zimmer Biomet (U.S.)
  5. Medtronic (Ireland)
  6. BioHorizons IPH, Inc. (U.S.)
  7. ACE Surgical Supply Company, Inc. (U.S.)
  8. RTI Surgical, Inc. (U.S.)
  9. LifeNet Health (U.S.)
  10. Dentium (Korea)

1. Introduction      

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods

               1.4 General Study Assumptions                 

2. Research Methodology                

               2.1 Introduction   

               2.2 Research Phases                      

    2.2.1 Secondary Research           

    2.2.2 Primary Research 

    2.2.3 Econometric Modelling      

    2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview           

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology  

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                  

               5.1 Product                       

    5.1.1 Introduction           

    5.1.2 Software  

    5.1.3 Molecular Simulation          

    5.1.4 In House   

    5.1.5 Contract Services  

    5.1.6  Y-o-Y Growth Analysis, By Product

    5.1.7  Market Attractiveness Analysis, By Product             

    5.1.8  Market Share Analysis, By Product              

               5.2 Application                 

    5.2.1 Introduction           

    5.2.2 Clinical Trials          

    5.2.3 PKPD         

    5.2.4 ADME       

    5.3.6 Y-o-Y Growth Analysis, By End-Use Industry              

    5.3.7  Market Attractiveness Analysis, By End-Use Industry          

    5.3.8  Market Share Analysis, By End-Use Industry            

               5.3 End User                     

    5.3.1 Introduction           

    5.3.2 Biotech Research  

    5.3.3 Pharma and Biotech Companies     

    5.3.4 CROs         

    5.3.5 Regulatory              

    5.3.6 Y-o-Y Growth Analysis, By End-Use Industry              

    5.3.7  Market Attractiveness Analysis, By End-Use Industry          

    5.3.8  Market Share Analysis, By End-Use Industry            

6. Geographical Analysis                  

               6.1 Introduction   

    6.1.1 Regional Trends    

    6.1.2 Impact Analysis     

    6.1.3 Y-o-Y Growth Analysis        

                   6.1.3.1 By Geographical Area

                   6.1.3.2 By Product

                   6.1.3.3 By Application

                   6.1.3.4 By End-User

    6.1.4  Market Attractiveness Analysis      

                   6.1.4.1 By Geographical Area

                   6.1.4.2 By Product

                   6.1.4.3 By Application

                   6.1.4.4 By End-User

    6.1.5  Market Share Analysis       

                   6.1.5.1 By Geographical Area

                   6.1.5.2 By Product

                   6.1.5.3 By Application

                   6.1.5.4 By End-User

               6.2 Middle-East    

               6.3 Africa

7. Strategic Analysis            

               7.1 PESTLE analysis                        

    7.1.1 Political    

    7.1.2 Economic 

    7.1.3 Social        

    7.1.4 Technological        

    7.1.5 Legal         

    7.1.6 Environmental       

               7.2 Porter’s Five analysis   

    7.2.1 Bargaining Power of Suppliers         

    7.2.2 Bargaining Power of Consumers     

    7.2.3 Threat of New Entrants      

    7.2.4 Threat of Substitute Products and Services

    7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis             

               8.1 Athersys                      

    8.1.1 Overview 

    8.1.2 Product Analysis   

    8.1.3 Financial analysis  

    8.1.4 Recent Developments        

    8.1.5 SWOT analysis       

    8.1.6 Analyst View          

               8.2 Certara (US)               

               8.3 Simulation Plus (US)               

               8.4   Dassault Systèmes (France)               

               8.5 Schrödinger (US)                     

               8.6 ACD/Labs (Canada)                 

               8.7 Chemical Computing Group (Canada)   

               8.8 Physiomics (UK)                       

               8.9 Evidera (US)               

               8.10  In silico biosciences (US)                   

               8.11 INOSIM Software (Germany)  

               8.12 Insilico Biotechnology (Germany)                   

               8.13 LeadInvent Technologies (India)                     

               8.14 Rosa (US)                 

               8.15 Nuventra Pharma (US)                       

               8.16 Genedata (Switzerland)                      

9. Competitive Landscape               

               9.1 Market share analysis 

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                

               a) List of Tables                

               b) List of Figures   

  • Global ,Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of market by product ,by application, by end user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Biosimulation Market By Region, From 2019-2024 ( USD Billion )
  2. Global Biosimulation Market By Product, From 2019-2024 ( USD Billion )
  3. Global Software Market By Region, From 2019-2024 ( USD Billion )
  4. Global Molecular Simulation Market By Region, From 2019-2024 ( USD Billion )
  5. Global In House Market By Region, From 2019-2024 ( USD Billion )
  6. Global Contract Services Market By Region, From 2019-2024 ( USD Billion )
  7. Global Biosimulation Market By Application, From 2019-2024 ( USD Billion )
  8. Global Clinical Trials Market By Region, From 2019-2024 ( USD Billion )
  9. Global PKPD Market By Region, From 2019-2024 ( USD Billion )
  10. Global ADME Market By Region, From 2019-2024 ( USD Billion )
  11. Global Biosimulation Market By End-User, From 2019-2024 ( USD Billion )
  12. Global Biotech Research Market By Region, From 2019-2024 ( USD Billion )
  13. Global Pharma & Biotech Companies Market By Region, From 2019-2024 ( USD Billion )
  14. Global CROs Market By Region, From 2019-2024 ( USD Billion )
  15. Global Regulatory Market By Region, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample